It's not like the company hasn't run any clinical trials yet. They have multiple completed ph 2's in different indications. He'd know what's needed better than most on this board. If he says a trial should start in 4th quarter, I'd expect it unless FDA comes up with some oddball reason not to.
Message in reply to:
Correct, The trial hype was Leo mentioning a 4Q start with zero facts to back him up. There’s still so much to be done before an actual date that Q4 seems remote now as September slips away. Data needed to be validated with focus on the FDA. So far silence...... Notice Leo never mentioned Aspire which casts more doubt about the June grant application.
News 
Market Data 
Discover 
